Logo-jpe
Submitted: 10 Feb 2021
Accepted: 04 May 2021
ePublished: 19 Jun 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2021;6(1): e04.
doi: 10.34172/jpe.2021.04
  Abstract View: 1208
  PDF Download: 505

Mini Review

Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge

Ghazal Ghasempour Dabaghi 1 ORCID logo, Mehrdad Rabiee Rad 1 ORCID logo, Lillian Saberian 2* ORCID logo

1 Nickan Research Institute, Isfahan, Iran
2 Independent Researcher and Author, Toronto, Ontario, Canada
*Corresponding Author: Correspondence to: Lillian Saberian, Email: , Email: leilasbrn626@gmail.com

Abstract

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is already known for its respiratory infection, but it involved more organs such as the kidney, liver, and heart. Most of the patients with COVID-19 have mild symptoms, but 5% of cases are admitted to an intensive care unit (ICU) for severe symptoms, including multi-organ failure and septic shock. Excessive immune responses play an essential role in sepsis development and are associated with worse prognosis in COVID-19 patients. Consequently, reduction of these immune responses may be helpful for managing COVID-19 patients. In this mini-review, we discuss the prospective role of CD24FC, as a recombinant protein with immunomodulatory function, in the treatment of COVID-19 patients and its mechanism of action in the regulation of the immune system.

Citation: Ghasempour Dabaghi G, Rabiee Rad M, Saberian L. Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge. J Prev Epidemiol. 2021;6(1):e04. doi: 10.34172/ jpe.2021.04.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1209

Your browser does not support the canvas element.


PDF Download: 505

Your browser does not support the canvas element.